Mylan (MYL) celebrates the Food and Drug Administration's go-ahead signal for its first biosimilar infection-fighting treatment Neulasta manufactured by Amgen (AMGN). Mylan
Categories
Other Industries
Twitter finally makes its way to the S&P 500
The struggling social media company Twitter (TWTR) will finally become a part of the S&P 500 index, effective before the bell on
Monsanto all set to disappear into Bayer
Bayer AG plans to close its $63-billion acquisition of Monsanto Company (MON) by this Thursday. Bayer said it would keep its name
General Electric needs a well-engineered solution to get back into shape
A freefalling stock and progressively shrinking dividend are something investors dread the most, and things turn really depressing when it comes from
Pfizer’s blockbuster drug Xeljanz snags FDA approval for ulcerative colitis
Pfizer’s (PFE) blockbuster drug Xeljanz has won itself a new regulatory approval to treat adults with inflammatory bowel disease (IBD). This recent
PVH earnings climb on Tommy Hilfiger and Calvin Klein businesses’ strength
PVH Corp (PVH) reported a 155% jump in earnings for the first quarter helped by broad-based strength across its businesses globally as
Bayer-Monsanto merger finalized after years of pursuit
The days of waiting for Bayer is finally over. The Germany based pesticide firm has crossed the final hurdle in its $66
Allergan to sell women’s health and infectious disease units
Allergan Plc (AGN) is planning to sell its women’s health and infectious disease businesses after completing its strategic review. The sale would
Startup Bird races to become the first electric-scooter unicorn
The new entrant in transportation options is the dockless electric scooters and the race to deploy these scooters in the US is
Alibaba joins Cainiao aboard the ZTO Express to cut off Amazon
Chinese online retailer Alibaba Group Holding Ltd (BABA) along with its logistics partner Cainiao Network is planning to acquire a 10% stake
Pandora quietly launches unlimited family plan
The internet radio services firm Pandora (P) has been around for a long but struggled to survive in an extremely competitive environment.
Netflix needs to balance subscriber growth and cash burn
Netflix Inc. (NFLX) stock has been on an upswing lately and touched a new 52-week high of $354.36 on Friday, up 123%
Just hours into GDPR regime, tech giants are staring at enormous fines
The privacy revolution has begun in Europe, and it’s going to be a rough ride for Silicon Valley. Just hours after the
GDPR is a shadow monster that can hunt down US firms
The deadline for companies having operations in the European Union (EU) to comply with the General Data Protection Regulation (GDPR) standards is
German automobile shares tank on US tariff fears
Brace yourselves, for your dream of that German supercar just got dearer. The shares of German autogiants Daimler, BMW, and Volkswagen slid
Roche’s latest trials prove wider use of new drug Hemlibra
Just a month after picking an accelerated review by U.S. regulators for its new blockbuster drug Hemlibra, the Swiss drugmaker Roche has
Tiffany stock surges on upbeat Q1 results, better outlook
Jewelry maker Tiffany & Co. (TIF) reported a 53% jump in earnings in the first quarter, riding on a 15% rise in
Surge in crude oil prices may spark a recession
A strong demand has been driving crude oil prices higher since last August, and many economists fear this could spark an economic
Celgene plunges to a new 52-week low battered by setbacks
On Monday, shares of the troubled pharma giant Celgene (CELG) succumbed to $74.13, its new 52-week low and ended the day at
Toll Brothers Q2 earnings miss Street’s expectations
Luxury homes builder Toll Brothers (TOL) reported a 10.3% drop in earnings for the second quarter due to higher selling, general and
NextEra Energy inks a deal to acquire certain assets of Southern Company
Energy producer NextEra Energy (NEE) has agreed to acquire Southern company's (SO) some assets including Florida City Gas, Gulf Power and the